Strata Critical Medical, Inc. (SRTA) › Cost of RevenueStrata Critical Medical, Inc. (SRTA) — Cost of RevenueAnnual figures by period end, from SEC filings.2019-09-30: $26.50M2020-09-30: $21.11M2021-09-30: $40.01M2022-12-31: $123.84M2023-12-31: $183.06M2024-12-31: $117.23M2025-12-31: $156.01M$156.01M2019-09-30Cost of Revenue (USD)2025-12-31Period endedCost of RevenueChange YoYSource filing2025-12-31$156.01M+33.1%2026-03-03From 2025-01-012024-12-31$117.23M-36.0%2026-03-03From 2024-01-012023-12-31$183.06M+47.8%2025-03-13From 2023-01-012022-12-31$123.84M—2024-03-12From 2022-01-012021-09-30$40.01M+89.5%2023-03-16From 2020-10-012020-09-30$21.11M-20.3%2021-12-20From 2019-10-012019-09-30$26.50M—2021-12-20From 2018-10-01Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)